4,861 research outputs found

    Impact of a methadone maintenance program on an Aboriginal community: a qualitative study

    Get PDF
    Abstract: Background: Methadone maintenance treatment programs implemented in Aboriginal communities have proven to be beneficial for the control of opioid addiction and its associated consequences, but the perceptions and opinions of different community members about these programs remain elusive. The goal of this study was to determine the perceptions of members of a First Nation community in New Brunswick, Canada, on the implementation of a methadone maintenance treatment program and its effects on the community. Methods: We conducted a qualitative study using semistructured focus group discussions with 3 distinct groups composed of health care professionals and influential community members, patients in the methadone maintenance treatment program and community members at large. Thematic analysis of discussion transcripts was performed. Results: A total of 22 partipants were included in the 3 focus groups. All groups of participants expressed that patients in the program are stigmatized and marginalized. Discussions also revealed widespread misconceptions about the program. Participants associated the program with improvements in community-level outcomes and in parenting abilities of patients, but also with difficulties preserving family unity. Interpretation: Despite being culturally adapted to the community, elements surrounding the methadone maintenance treatment program in this First Nation community appear to be misunderstood and stigmatized. It may be beneficial to provide community education on these programs to assure community buy-in for the successful implementation of harm reduction programs in Aboriginal communities

    Wie effektiv sind Methadonbehandlungen in Privatpraxen∋

    Get PDF
    Summary: Objectives:Involvement of private practitioners in methadone maintenance treatment (MMT) enhances its availability. However, effectiveness of such treatments is still debated. Methods:A retrospective case register analysis comparing the retention of private practices with that of specialised institutions. All methadone maintenance treatment starting between January 1, 1997 and December 31, 1999. Kaplan-Meier survival estimates to test for different retention times; Cox-regression procedure to control for baseline differences between the two populations. Results:Even after controlling for distinct patient characteristics, MMT by private practitioners resulted in a longer retention time. Conclusions:Our findings favour the involvement of private practitioners. Providing better professional and financial support may enhance their participatio

    Family Related Factors and Concurrent Heroin Use in Methadone Maintenance Treatment in China.

    Get PDF
    BackgroundThe use of heroin during Methadone Maintenance Treatment (MMT) is a challenging problem that contributes to poor treatment outcomes. Families may play an important role in addressing concurrent heroin use during MMT, especially in collectivist societies such as China.ObjectivesIn this study, we explored the relationship between family-related factors and concurrent heroin use during MMT in China.MethodsThis study was conducted at 68 MMT clinics in five provinces of China. There were 2,446 MMT clients in the analysis. Demographic information, MMT dosage, family members' heroin use status, family support of MMT, family problem, and self-reported heroin use were collected in a cross-sectional survey. The most recent urinalysis of opiate use was obtained from clinical records.ResultsOf the 2,446 participants, 533 (21.79%) self-reported heroin use in the previous seven days or had a positive urine morphine test result in the clinic record. Participants whose family member[s] used heroin were 1.59 times (95% CI: 1.17, 2.15) more likely to use concurrently during treatment. Those with family members who totally support them on the MMT were less likely to use (AOR: 0.75, 95% CI: 0.60, 0.94). Having more family problems was positively associated with concurrent heroin use (AOR: 2.01, 95% CI: 1.03, 3.93).ConclusionsThe results highlight the importance of the family's role in concurrent heroin use during MMT programs. The study's findings may have implications for family-based interventions that address concurrent heroin use

    Impact of Physical Activity on Stress Levels and Methadone Maintenance Treatment Outcomes

    Get PDF
    Introduction: While the opioid epidemic has continued to intensify over the last decade, unfortunately the likelihood of achieving stable long-term abstinence using methadone maintenance treatment (MMT) remains as low as 60 percent. Perceived stress has been identified as a factor predictive of premature termination and relapse, making stress reduction an important area of study in MMT. However, little research is available on the effects of active stress-coping mechanisms on MMT outcomes. Objective: To address this gap, the current study was conducted to examine the impact of physical activity on stress reduction and treatment outcomes. Methods: This was a retrospective cohort study in which ninety-three consecutive admissions to a university sponsored, community-based, outpatient medication-assisted treatment facility in Pennsylvania were reviewed. The 46 individuals (49.5%) who remained active in treatment at 6 months post-admission represented the study sample. Thirty-four of these individuals completed an initial assessment with the 4-item Perceived Stress Scale (PSS4) allowing investigators to determine stress levels at admission. The 27 individuals scoring above the 25th percentile were categorized as “high stress” and retained for further interviewing. Of these 27 individuals, 22 completed both the 10-item Perceived Stress Scale (PSS10) to assess stress levels at approximately 6 months post-admission as well the Global Physical Activity Questionnaire (GPAQ), which measured physical activity levels at admission and 6 months post-admission. Results: The mean age at time of study was 40. 52± 11.84 years; 68% of study participants were male, 65% were Caucasian, 79% were unemployed, and 91% were unmarried. In the first 180 days of treatment, subjects were dosed on average of 164.02 days (91. 1%) with the average dose equaling 85. 40± 40.2 milligrams per day. Consistent with prior research, results indicated that stress levels dropped significantly from admission to 6 months post-entry from a mean stress level of 2. 82±.59 to 1.88±. 80, t(22)=4. 971, p Conclusion: Our data, based on a limited sample, suggests that treatment is associated with decreased levels of stress levels in this population. Interestingly, patients attributed their decreased physical activity levels to reduced or nonexistent drug-seeking activity, as well as to the demanding time-commitment of MMT. Our failure to find significant effects of exercise may be a consequence of sampling procedures and sample size. To better address this question, future controlled studies might focus on incorporating physical exercise in MMT treatment to determine if those who regularly engage in physical activity demonstrate better outcomes in MMT. Identification of positive effects will allow the medical community to introduce non-pharmaceutical approaches to the treatment of opioid use disorders

    The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.

    Get PDF
    This prospective patient-preference study examined the effectiveness in practice of methadone versus buprenorphine maintenance treatment and the beliefs of subjects regarding these drugs. A total of 361 opiate-dependent individuals (89% of those eligible, presenting for treatment over 2 years at a drug service in England) received rapid titration then flexible dosing with methadone or buprenorphine; 227 patients chose methadone (63%) and 134 buprenorphine (37%). Participants choosing methadone had more severe substance abuse and psychiatric and physical problems but were more likely to remain in treatment. Survival analysis indicated those prescribed methadone were over twice as likely to be retained (hazard ratio for retention was 2.08 and 95% confidence interval [CI] = 1.49-2.94 for methadone vs. buprenorphine), However, those retained on buprenorphine were more likely to suppress illicit opiate use (odds ratio = 2.136, 95% CI = 1.509-3.027, p < .001) and achieve detoxification. Buprenorphine may also recruit more individuals to treatment because 28% of those choosing buprenorphine (10% of the total sample) stated they would not have accessed treatment with methadone

    Treating Homeless Opioid Dependent Patients with Buprenorphine in an Office-Based Setting

    Get PDF
    CONTEXT Although office-based opioid treatment with buprenorphine (OBOT-B) has been successfully implemented in primary care settings in the US, its use has not been reported in homeless patients. OBJECTIVE To characterize the feasibility of OBOT-B in homeless relative to housed patients. DESIGN A retrospective record review examining treatment failure, drug use, utilization of substance abuse treatment services, and intensity of clinical support by a nurse care manager (NCM) among homeless and housed patients in an OBOT-B program between August 2003 and October 2004. Treatment failure was defined as elopement before completing medication induction, discharge after medication induction due to ongoing drug use with concurrent nonadherence with intensified treatment, or discharge due to disruptive behavior. RESULTS Of 44 homeless and 41 housed patients enrolled over 12 months, homeless patients were more likely to be older, nonwhite, unemployed, infected with HIV and hepatitis C, and report a psychiatric illness. Homeless patients had fewer social supports and more chronic substance abuse histories with a 3- to 6-fold greater number of years of drug use, number of detoxification attempts and percentage with a history of methadone maintenance treatment. The proportion of subjects with treatment failure for the homeless (21%) and housed (22%) did not differ (P=.94). At 12 months, both groups had similar proportions with illicit opioid use [Odds ratio (OR), 0.9 (95% CI, 0.5–1.7) P=.8], utilization of counseling (homeless, 46%; housed, 49%; P=.95), and participation in mutual-help groups (homeless, 25%; housed, 29%; P=.96). At 12 months, 36% of the homeless group was no longer homeless. During the first month of treatment, homeless patients required more clinical support from the NCM than housed patients. CONCLUSIONS Despite homeless opioid dependent patients' social instability, greater comorbidities, and more chronic drug use, office-based opioid treatment with buprenorphine was effectively implemented in this population comparable to outcomes in housed patients with respect to treatment failure, illicit opioid use, and utilization of substance abuse treatment
    • 

    corecore